GfK Insights Blog

Wednesday, 1. April 2015 - You're not logged in. Log in »

Recent Posts

Omni-being: striving against digital dualism

March 31, 2015 by in Financial services

On a recent Silicon Valley business trip, a couple of colleagues and I took a break for lunch in Palo Alto. The inviting 72 degree sunny day for this northeast winter-sufferer made it hard to resist a casual neighborhood café with outdoor seating. Our hostess quickly sat us down and deposited our server on the table; that is, a self-serve menu tablet which would serve as our order taker and cashier. Our only other human interaction came from what was essentially a food runner/server, and a drop-by from someone obviously in management role who checked on our satisfaction with everything. In fact all was quite easy and satisfying, with the exception of wanting to probe a bit more about the specials, identify alternatives to fries on the side, and get directions to the restroom.

Bringing millennials to your table: 3 ways to adapt to millennials’ changing lifestyles

March 30, 2015 by in Consumer Goods, Retail

From Quick Serve to White Tablecloths, restaurants all count on Millennials coming through their doors to meet sales goals. Many QSR and CDR marketers, however, are concerned about sales dips among these consumers. More and more, these marketers are asking, “Where are my Millennials going?”

According to GfK MRI’s Survey of the American Consumer, the percentage of Millennials who are quick to grab a burger or a sub from leading value-priced QSR burger or sandwich chains has decreased since 2011. It has also dropped at CDR chains, where table service and drinks are the standard.

Financial squeeze is risky for the cancer drugs fund list in the UK

March 27, 2015 by in Health

The Cancer Drugs Fund (CDF) has come under increasing financial pressure as the National Institute for Health and Care Excellence (NICE) has continued to restrict or deny access to new cancer medicines. In July 2013 the government announced an increase in annual funding from £200m to £280m for the years 2014 to 2016. However, NHS England realized very soon that even with the extra funding, there would be a shortfall this year and next.

Therefore, they decided they needed to take action. Following a short consultation process in the autumn, they introduced two measures:

Hispanic millennials – pet marketers’ next best bet

March 26, 2015 by in Retail

Pet marketers are on the trail of something important. They need to track down their next generation of dominant customers. Baby Boomers, who account for a meaningful share of sales, are aging – and so are their pets. The pet industry is worried that, when Boomers’ dogs and cats pass away, they will not be replaced and sales will suffer.

Benefits and challenges of submitting to the medical technologies evaluation programme

March 25, 2015 by in Health

In 2009, the National Institute for Health and Care Excellence (NICE) was tasked with establishing a system that could identify and encourage the adoption of new or novel medical devices and diagnostic technologies. After discussions with key stakeholders, NICE developed the Medical Technologies Evaluation Programme (MTEP), which is tasked with improving the experiences and outcomes of patients and/or driving efficiencies in the use of UK health-service resources. [1]

As of January 2015, MTEP has assessed and published guidance for 22 medical technologies.

Once a company has chosen to submit a product for the MTEP, a team from NICE assesses the technology’s eligibility for evaluation against the eligibility criteria. The criteria [2] are:

What do American drivers want from tomorrow’s car infotainment systems?

March 24, 2015 by in Automotive, Media & entertainment, Technology

In a competitive global marketplace, one key way for auto manufacturers to keep customers satisfied is to anticipate and meet their future wants and desires. We asked drivers what multimedia and entertainment features they might want in tomorrow’s car.What they wanted differed by market – sometimes a little, but for some factors quite significantly. This means car manufacturers need to adapt their models for each country, and to do that they need to understand those market differences.

How social media can give power blender manufacturers a bigger cut of the market

March 23, 2015 by in Retail, Technology

How seriously should manufacturers of small appliances take social media as a channel for communicating with consumers? According to our Social Media Intelligence (SMI) analysis focusing on power blenders, German consumers are very willing to share their experiences, views and advice with others this way. We listened to online conversations to understand how people research the category and their view on the relative positioning of different brands. What we uncovered makes for interesting reading for manufacturers who can use this information when planning their communication tactics and strategies.

Understanding the indonesian smartphone user

March 20, 2015 by in Retail, Technology

Indonesia often falls into the long shadow cast by other developing markets – Brazil, Russia, India and China – also known as the BRIC countries. But with the fourth largest population in the world, Indonesia is growing rapidly, as evidenced by the growth in smartphones.

The digital picture

Several factors have come together to create a ‘perfect storm’ driving the move to digital in Indonesia. Almost half of the population is under 30, there’s been a rapid rise in the emerging middle class and there is a strong cultural desire to be part of a community. These factors have created a new and dynamic class of digital consumers who are using their connected devices not just to work and play, but also to make life easier.

Pricing research for orphan drugs: time for a methodology change

March 19, 2015 by in Health

In 2013 Vertex Pharmaceuticals introduced Kalydeco® (ivacaftor), the first orphan drug to successfully treat the underlying cause of cystic fibrosis in a well-defined patient subgroup, into the Irish market. The annual cost was €234,804 per patient. With this price tag the new drug had the potential to deplete over 40% of the funding available for all new drug treatments in Ireland. A cost-effective analysis conducted by the Irish National Centre for Pharmacoeconomics showed that the ICER (incremental cost-effectiveness ratio) was around five times higher than the acceptable threshold suggested by NICE. [1] The obvious outcome of this negative assessment was the decision to not recommend reimbursement of the drug.

The power of “where”: better insights through location-enhanced business intelligence

March 18, 2015 by in Technology

Business intelligence (BI) systems and solutions have long been a valuable tool used by companies to organize and analyze information related to their markets and operations. The amount of data available to companies has grown exponentially in the past decade, which has increased demand for BI solutions that manage and make sense of this mountain of information. A quantum leap forward in the evolution of BI is the ability to link, analyze and display information based on a shared geographic component, such as postcodes. So-called “location-enhanced” BI allows users to extract insights from the spatial relationships contained in their data, an approach that often reveals startling new perspectives that would not otherwise be apparent in conventional tabular form.